{"protocolSection":{"identificationModule":{"nctId":"NCT06475924","orgStudyIdInfo":{"id":"MS 522/2023"},"organization":{"fullName":"Ain Shams University","class":"OTHER"},"briefTitle":"Relation Between Position of the Uterus (Anteversion or Retroversion Flexion) and Degree of Cesarean Scar Niche","officialTitle":"Relation Between Position of the Uterus (Anteversion or Retroversion Flexion) and Degree of Cesarean Scar Niche : Cross -Sectional Study"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-10-15","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-07","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-09","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-16","studyFirstSubmitQcDate":"2024-06-20","studyFirstPostDateStruct":{"date":"2024-06-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-20","lastUpdatePostDateStruct":{"date":"2024-06-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Maya Abdelrazek","investigatorTitle":"dr_maya89@med.asu.edu.eg","investigatorAffiliation":"Ain Shams University"},"leadSponsor":{"name":"Ain Shams University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study aims to determine the association between the size of caesarean scar niche and uterine position in childbearing women.\n\nResearch hypothesis: There is a relation between uterine position and degree of cesarean scar niche.\n\nResearch question: Is there a relation between uterine position and degree of cesarean scar niche?","detailedDescription":"It has been noted that the cesarean scar defect in patients with retroflexed uteri appear to be larger than are those in patients with anteverted uteri.\n\nThis study will describe the association between position of the uterus whether share in degree of cesarean scar niche or not and associated symptoms.\n\nPrimary outcome:\n\nThe association between the position of the uterus (Anteverted/Retroverted) and large CSD (the ratio between the depth and adjacent myometrial thickness)\n\nSecondary outcomes:\n\nThe association between position of the uterus (Anteverted/Retroverted) and:\n\n* Residual myometrial thickness (RMT).\n* Depth, Width, Length of SCD.\n\nThe association to the clinical symptoms as:\n\n* Postmenstrual spotting: more than 2 days of intermenstrual spotting, or more than 2 days of brownish discharge after the end of menstruation if bleeding duration exceeds 7 days (discharge is considered normal if bleeding duration is \\< 7 days).\n* Abnormal uterine bleeding (AUB) as per FIGO guideline.\n* Pain as dysmenorrhea, chronic pelvic pain or dyspareunia. If present will be assed using Visual Analogue Scale (VAS).\n* Secondary infertility: inability of a couple to conceive after one year of regular, unprotected intercourse."},"conditionsModule":{"conditions":["Anteversion of Uterus","Retroflex Uterus","CSD"],"keywords":["Cesarean scar defefect","Isthmocele","Caesarean scar niche","Anteverted uterus","Retroverted uterus"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"DIAGNOSTIC","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":85,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Cesarean Scar Defect (CSD)","type":"OTHER","description":"cesarean scar niche/defect (CSD) by transvaginal ultrasound that is defined as \"indentation at the site in the cesarean section scar with a depth of at least 2 mm\" that was agreed upon in 2019 by a European task force","interventionNames":["Diagnostic Test: Caesarean scar defect evlauation by ultraosund"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"Caesarean scar defect evlauation by ultraosund","description":"Women will be examined in the lithotomy position with an empty bladder. The uterus will be examined in a standardized way excluding causes of abnormal uterine bleeding or pelvic pain (myoma, polyp, pelvic inflammatory disease, adenomyosis).\n\nUpon detection of the SCD, the following will be measured:\n\nIn the midsagittal plane: the depth (the vertical distance between the base and apex of the defect), width (the length of the widest gap along the cervicoisthmic canal), residual myometrial thickness (RMT) overlying the defect, and the adjacent myometrial thickness fundal to the defect.\n\nIn the transverse plane: the length of the defect.\n\nThe uterine position will be classified as anteverted or retroverted.\n\nClinical symptoms of the patients will be reviewed such as :Postmenstrual spotting, Abnormal uterine bleeding, Pain, Secondary infertility.","armGroupLabels":["Cesarean Scar Defect (CSD)"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"correlation between position of the uterus and large Cesarean Scar defect (CSD)","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), which will be correlated to the presence of Large CSD (ratio between the depth (mm) and adjacent myometrial thickness (mm) more than or equal to 0.50)","timeFrame":"through study completion, up to 6 months"}],"secondaryOutcomes":[{"measure":"correlation between position of uterus and Residual myometrial thickness","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and measuring the thickness of the myometrium over the SCD (mm)","timeFrame":"through study completion, up to 6 months"},{"measure":"correlation between position of uterus and Depth, Length, Width of SCD","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and measure depth (mm) and width (mm) of the Cesarean scar defect, while in transverse plane of the uterus measure length (mm) of the cesarean scar defect.","timeFrame":"through study completion, up to 6 months"},{"measure":"correlation between position of uterus and postmenstrual spotting","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates to the presence of more than or equal to 2 days of intermenstrual spotting or more than or equal to 2 days of brownish discharge after the end of menstruation if bleeding duration exceeds 7 days (discharge is considered normal if bleeding duration is less than 7 days)","timeFrame":"through study completion, up to 6 months"},{"measure":"correlation between position of uterus and Abnormal Uterine Bleeding (AUB)","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates to the presence of AUB as per Figo guideline as regards frequency (in days), duration (in days), regularity (Regular/irregular) and intermenstrual bleeding","timeFrame":"through study completion, up to 6 months"},{"measure":"correlation between position of uterus and Pelvic Pain","description":"By using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates it to the presence of Dysmenorrhea, Chronic pelvic pain or dyspareunia.","timeFrame":"through study completion, up to 6 months"},{"measure":"correlation between position of uterus and secondary infertility","description":"secondary infertility is defined as inability of a couple to conceive after 1 year of regular, unprotected intercourse.","timeFrame":"through study completion, up to 6 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Women in childbearing age.\n* At least six months postpartum.\n* With cesarean scar niche/defect (CSD) by transvaginal ultrasound that is defined as \"indentation at the site in the cesarean section scar with a depth of at least 2 mm\" that was agreed upon in 2019 by a European task force\n\nExclusion Criteria:\n\n* Severely Obese (Body mass index; BMI more than or equal to 35 kg/m2).\n* Women with abnormal uterine pathology, observed during the ultrasound examination that may have been responsible for abnormal uterine bleeding, including endometrial hyperplasia, polyps, malignancy or myomas.\n* Women with any cause of pelvic pain as pelvic inflammatory diseases, endometriosis or adenomyosis.\n* Women with history of classic upper segment cesarean section or hysterotomy.\n* Women with history of previous uterine scars rather than cesarean sections as myomectomy.\n* Women with bleeding tendency disorders, taking anticoagulants or having chronic medical conditions as liver diseases, or coagulopathies.","healthyVolunteers":false,"sex":"FEMALE","genderBased":true,"genderDescription":"women in child bearing age with history of previous cesarean section and at least 6 months postpartum.","minimumAge":"18 Years","maximumAge":"49 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Maya M. Abdelrazek","role":"CONTACT","phone":"01222393983","email":"dr_maya89@med.asu.edu.eg"}],"overallOfficials":[{"name":"Maya M. Abdelrazek","affiliation":"Ain Shams University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Ain Shams University","status":"RECRUITING","city":"Cairo","country":"Egypt","contacts":[{"name":"Sarah Safwat","role":"CONTACT","phone":"+201111343606"},{"name":"Naema Khalil Hassan Ali","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":30.06263,"lon":31.24967}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"browseLeaves":[{"id":"M6160","name":"Cicatrix","relevance":"LOW"},{"id":"M29672","name":"Uterine Retroversion","relevance":"LOW"},{"id":"T4202","name":"Oculocerebral Syndrome With Hypopigmentation","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXS","name":"Urinary Tract, Sexual Organs, and Pregnancy Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}